Myeloid dendritic cells (DCs) of mice susceptible to paracoccidioidomycosis suppress T cell responses whereas myeloid and plasmacytoid DCs from resistant mice induce effector and regulatory T cells

Infection and Immunity

Volumn 81, Issue 4, 2013, Pages 1064-1077

  Pina, Adriana ^a   de Araujo, Eliseu Frank ^a   Felonato, Maíra ^a   Loures, Flávio V ^a   Feriotti, Claudia ^a   Bernardino, Simone ^a   Barbuto, José Alexandre M ^a   Calich, Vera L G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD40 LIGAND; CD44V6 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; IMMUNOMODULATION; IN VIVO STUDY; INFECTION SENSITIVITY; INNATE IMMUNITY; LUNG INFECTION; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SOUTH AMERICAN BLASTOMYCOSIS;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; DISEASE SUSCEPTIBILITY; GENE EXPRESSION PROFILING; MICE; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; T-LYMPHOCYTES;

EID: 84875523202     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00736-12     Document Type: Article

References (61)

1. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
3. Sallusto F. 1999. The role of chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses. Haematologica 84 (Suppl EHA-4):28-31.
4. Colonna M, Trinchieri G, Liu YJ. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5:1219-1226.
5. Fonteneau JF, Kavanagh DG, Lirvall M, Sanders C, Cover TL. 2003. Characterization of the MHC class I cross-presentation pathway for cellassociated antigens by human dendritic cells. Blood 102:4448-4455.
6. Hadeiba H, Sato T, Habtezion A, Oderup C, Pan J. 2008. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 9:1253-1260.
7. Young LJ, Wilson NS, Schnorrer P, Proietto A, Broeke T. 2008. Differential MHC class II synthesis and ubiquitination confer distinct antigenpresenting properties on conventional and plasmacytoid dendritic cells. Nat. Immunol. 9:1244-1252.
8. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA. 2001. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194:863-869.
9. Netea MG, Gow NA, Munro CA, Bates S, Collins C. 2006. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest. 116:1642-1650.
10. Romani L. 2011. Immunity to fungal infections. Nat. Rev. Immunol. 11:275-288.
11. Bellocchio S, Moretti S, Perruccio K, Fallarino F, Bozza S. 2004. TLRs govern neutrophil activity in aspergillosis. J. Immunol. 173:7406-7415.
12. Muller U, Stenzel W, Köhler G, Werner C, Polte T, Hansen G, Schultze N, Straibinger RK, Blessing M, Mckenzie AN, Brombacher F, Alber G. 2007. IL-13 promotes disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J. Immunol. 179:5367-5377.
13. Robinson MJ, Osorio F, Rosas M, Freitas RP, Schweighoffer E, Grob O, Verbeek JS, Ruland J, Tybulewicz V, Brown GD, Moita LF, Taylor PR, Reis e Souza C. 2009. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for IL-17 responses to fungal infection. J. Exp. Med. 206: 2037-2051.
14. Brummer E. 1994. Interaction of Paracoccidioides brasiliensis with host defense cells, p 213-223. In Franco M, Lacaz CS, Moreno AR, Negro GD (ed), Paracoccidioidomycosis. CRC Press, Boca Raton, FL. 15. Franco MF. 1987. Host parasite relationship in paracoccidioidomycosis. J. Med. Vet. Mycol. 25:5-18.
15. Franco MF. 1987. Host parasite relationship in paracoccidioidomycosis. J. Med. Vet. Mycol. 25:5-18.
16. Benard G, Mendes-Giannini MJ, Juvenale M, Miranda ET, Duarte AJS. 1997. Immunosuppression in paracoccidioidomycosis: T cell hyporesponsiveness to two Paracoccidioides brasiliensis glycoproteins that elicit strong humoral immune response. J. Infect. Dis. 175:1263-1267.
17. Calich VLG, Blotta MH. 2005. Pulmonary paracoccidioidomycosis, p 201-228. In Fidel PL, Huffnagle GB (ed), Fungal immunology. Springer, New York, NY.
18. Mamoni RL, Nouer AS, Oliveira SJ, Musatti CC, Rossi CL. 2002. Enhanced production of specific IgG4, IgE and TGF-beta in sera from patients with the juvenile form of paracoccidioidomycosis. Med. Mycol. 40:153-159.
19. Cacere CR, Mendes-Giannini MJ, do Valle AC, Duarte AJ, Benard G. 2009. Altered ex vivo expression of caspase 8, caspase 9, and Bcl-2 is associated with T-cell hyporeactivity in patients with paracoccidioidomycosis. Clin. Vaccine Immunol. 16:953-955.
20. Cacere CR, Romano CC, Mendes-Giannini MJ, Duarte AJ, Benard G. 2002. The role of apoptosis in the antigen-specific T cell hyporesponsiveness of paracoccidioidomycosis patients. Clin. Immunol. 105:215-222.
21. Cavassani KA, Campanelli AP, Moreira AP, Vancim JO, Vitali LH. 2006. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J. Immunol. 177:5811-5818.
22. Calich VLG, Costa TA, Felonato M, Arruda C, Bernardino S. 2008. Innate immunity to Paracoccidioides brasiliensis infection. Mycopathologia 165:223-236.
23. Cano LE, Singer-Vermes LM, Vaz CAC, Russo M, Calich VLG. 1995. Pulmonary paracoccidioidomycosis in resistant and susceptible mice, relationship among progression of infection, bronchoalveolar cell activation, cellular immune response, and specific isotype patterns. Infect. Immun. 63:1777-1783.
24. Kashino SS, Fazioli RA, Cafalli-Favati C, Meloni-Bruneri LH, Calich VLG. 2000. Resistance to Paracoccidioides brasiliensis infection is linked to a preferential Th1 immune response, whereas susceptibility is associated with absence of IFN-γ production. J. Interferon Cytokine Res. 20:89-97.
25. Nascimento FRF, Calich VLG, Rodríguez D, Russo M. 2002. Dual role for nitric oxide in paracoccidioidomycosis, essential for resistance, but overproduction associated with susceptibility. J. Immunol. 168:4593-4600.
26. Pina A, Bernardino S, Calich VLG. 2008. Alveolar macrophages from susceptible mice are more competent than those of resistant mice to control initial Paracoccidioides brasiliensis infection. J. Leukoc. Biol. 83:1088-1093.
27. Pina A, Saldiva PH, Restrepo LE, Calich VLG. 2006. Neutrophil role in pulmonary paracoccidioidomycosis depends on the resistance pattern of hosts. J. Leukoc. Biol. 79:1202-1213.
28. Cano LE, Kashino SS, Arruda C, André D, Calich VLG. 1998. Protective role of gamma interferon in experimental pulmonary paracoccidioidomycosis. Infect. Immun. 66:800-806.
29. Chiarella AP, Arruda C, Pina A, Costa TA, Calich VLG. 2007. The relative importance of CD4β and CD8β T cells in immunity to pulmonary paracoccidioidomycosis. Microbes Infect. 9:1078-1088.
30. Arruda C, Franco MF, Kashino SS, Nascimento FR, Calich VLG. 2002. Interleukin-12 protects mice against disseminated infection caused by Paracoccidioides brasiliensis but enhances pulmonary inflammation. Clin. Immunol. 103:185-195.
31. Arruda C, Valente-Ferreira RC, Pina A, Kashino SS, Calich VLG. 2004. Dual role of interleukin-4 (IL-4) in pulmonary paracoccidioidomycosis: endogenous IL-4 can induce protection or exacerbation of disease depending on the host genetic pattern. Infect. Immun. 72:3932-3940.
32. Cano LE, Singer-Vermes LM, Mengel JA, Xidieh CF, Calich VLG. 2000. Depletion of CD8β T cells in vivo impairs host defense of resistant and susceptible mice to pulmonary paracoccidioidomycosis. Infect. Immun. 68:352-359.
33. Kashino SS, Singer-Vermes LM, Calich VLG, Burger E. 1990. Alterations in the pathogenicity of one Paracoccidioides brasiliensis isolate do not correlate with its in vitro growth. Mycopathologia 111:173-180.
34. Fava Netto C, Vegas VS, Sciannaméa IM, Guarnieri EDB. 1969. Antígeno polissacarídico do Paracoccidioides brasiliensis: estudo do tempo de cultivo do P. brasiliensis necessário ao preparo do antígeno. Rev. Inst. Med. Trop. 11:177-181.
35. Inaba K, Inaba M, Romani N, Aya H, Steinman RM. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophages colony-stimulating factor. J. Exp. Med. 176:1693-1702.
36. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 184:39-51.
37. Lyons AB. 2000. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243: 147-154.
38. Trinchieri G, Santoli D, Dee RR, Knowles BB. 1978. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virustransformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J. Exp. Med. 147:1299-1313.
39. Arruda C, Kashino SS, Fazioli RA, Calich VLG. 2007. A primary subcutaneous infection with Paracoccidioides brasiliensis leads to immunoprotection or exacerbated disease depending on the route of challenge. Microbes Infect. 9:308-316.
40. Fazioli RA, Singer-Vermes LM, Kashino SS, Burger E, Calich VLG. 1994. Delayed-type hypersensitivity response in an isogenic murine model of paracoccidioidomycosis. Mycopathologia 126:137-146.
41. Ferreira KS, Almeida SR. 2006. Immunization of susceptible mice with gp43-pulsed dendritic cells induces an increase of pulmonary paracoccidioidomycosis. Immunol. Lett. 103:121-126.
42. Ferreira KS, Bastos KR, Russo M, Almeida SR. 2007. Interaction between Paracoccidioides brasiliensis and pulmonary dendritic cells induces interleukin-10 production and Toll-like receptor-2 expression: possible mechanisms of susceptibility. J. Infect. Dis. 196:1108-1115.
43. Ferreira KS, Lopes JD, Almeida SR. 2004. Down-regulation of dendritic cell activation induced by Paracoccidioides brasiliensis. Immunol. Lett. 94: 107-114.
44. Geissman FP, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. 2010. Development of monocytes, macrophages and dendritic cells. Science 327:656-661.
45. Shortman K, Naik SH. 2007. Steady-state and inflammatory dendriticcell development. Nat. Rev. Immunol. 7:19-30.
46. Gilliet M, Boonstra A, Trinchieri G, O'Garra A, Liu YJ. 2002. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colonystimulating factor. J. Exp. Med. 195:953-958.
47. Cousens LP, Peterson R, Ahmed R, Biron CA. 1999. Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J. Exp. Med. 189:1315-1328.
48. Ramirez-Ortiz ZG, Lee CK, Wang JP, Boon L, Specht CA, Levitz SM. 2011.Anonredundant role for plasmacytoid dendritic cells in host defenseagainst the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe 9:415-424.
49. Romani L, Bistoni F, Gaziano R, Bozza S, Montagnoli C, Perruchio K, Pitzurra L, Belochio S, Velardi A, Rasi G, Francesco P, Garaci E. 2004. Thymosin a activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling. Blood 103:4232-4239.
50. Geissmann FP, Revy A, Regnault Y, Lepelletier M, Dy N. 1999. TGFbeta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162:4567-4575.
51. Belkaid Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7:875-888.
52. O'Garra A, Vieira P. 2004. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10:801-805.
53. Felonato M, Pina A, de Araujo EF, Loures FV, Bazan SB, Feriotti C, Calich VL. 2012. Anti-CD25 treatment depletes Treg cells and decreases disease severity in susceptible and resistant mice infected with Paracoccidioides brasiliensis. PLoS One 7:e51071. doi:10371/journal.pone.0051071.
54. Bonifazi P, Zelante T, Fallarino F, Puccetti P, Romani L. 2009. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol. 2:362-374.
55. Leepiyasakulchai C, Ignatowicz L, Pawlowski A, Källenius G, Sköld M. 2012. Failure to recruit anti-inflammatory CD103β dendritic cells and a diminished CD4β Foxp3β regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosis. Infect. Immun. 80:1128-1139.
56. Neill DR, Fernandes VE, Wisby L, Haynes AR, Ferreira DM, Laher A, Strickland N, Gordon SB, Denny P, Kadioglu A, Andrew PW. 2012. T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice. PLoS Pathog. 8:e1002660. doi:10.1371/journal.ppat.1002660.
57. Clarke D. 1986. Tolerance of parasites and disease in plants and its significance in host-parasite interactions. Adv. Plant Pathol. 5:161-197.
58. Råberg L, Sim D, Read AF. 2007. Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science 318: 812-814.
59. Schneider DS, Ayres JS. 2008. Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat. Rev. Immunol. 8:889-895.
60. Grysckek RCB, Pereira RM, Kono A, Shikanai-Yasuda MA, Benard G. 2010. Paradoxical reaction to treatment in two patients with severe acute paracoccidioidomycosis: a previously unreported complication and its management with corticosteroids. Clin. Infect. Dis. 50:56-58.
61. Hahn PY, Limper AH. 2003. The role of inflammation in respiratory impairment during Pneumocystis carinii pneumonia. Semin. Respir. Infect. 18:40-47.